[Press Release] Global Vascular Selected for NEDO’s Deep–Tech Startups Support Program
- m-kawabe7
- 2 days ago
- 1 min read
Global Vascular Co., Ltd. (Headquarters: Tokyo, Japan) has been selected as a recipient of a subsidy under the 8th public call for proposals by the New Energy and Industrial Technology Development Organization (NEDO) for the “Deep-Tech Startups Support Fund / Deep-Tech Startups Support Program (DTSU Program).”
NEDO’s DTSU Program supports R&D from a medium- to long-term perspective to accelerate the development, commercialization, and societal implementation of innovative technologies originating from deep–tech startups. Through this initiative, NEDO promotes the social deployment of technologies that contribute to addressing economic and social challenges, while fostering the creation of new companies and industries.
Lower Extremity Artery Disease (LEAD), an ischemic disease that affects the arteries in the lower limbs, is estimated to have a potential patient population of more than 200 million worldwide. In particular, the below-the-knee(BTK) vascular region remains challenging for achieving long–term patency treatment because narrow vessel diameters and slow blood flow increase the risk of restenosis.
Through the development of the BioStealth™ drug-eluting stent*, we aim to create a future in which LEAD patients–especially those who have long faced limited treatment options–can receive therapy with confidence and benefit from sustained treatment outcomes.
*BioStealth™ is a concept for a stent that we are currently developing.
We will continue working to address unmet medical needs in difficult-to-treat vascular regions, so that people worldwide can continue to enjoy the simple yet essential act of walking for years to come.
[NEDO Announcement | January 9, 2026 (Japanese only)]
